View in EDS PDF Full Text

GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.

Saved in:
Bibliographic Details
Title: GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
Authors: Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Fernandez-Barrena MG; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Iguchi E; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., McCleary-Wheeler AL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Carr RM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Flores LF; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Vera RE; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Alfonse GW; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Hogenson TL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Vrabel AM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Horn IP; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Koenig AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Safgren SL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Erkan M; Department of Surgery, Koc University School of Medicine, Istanbul, Turkey., Romecin-Duran PA; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Sarabia Gonzalez A; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Zhou B; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Javelaud D; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France., Marsaud V; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France., Graham RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, U.S.A., Mauviel A; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France., Elsawa SF; Department of Molecular, Cellular and Biomedical Sciences, College of Life Sciences and Agriculture, University of New Hampshire, Durham, NH, U.S.A., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
Source: The Biochemical journal [Biochem J] 2020 Sep 18; Vol. 477 (17), pp. 3131-3145.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Published by Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 2984726R Publication Model: Print Cited Medium: Internet ISSN: 1470-8728 (Electronic) Linking ISSN: 02646021 NLM ISO Abbreviation: Biochem J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32766732
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tolosa+EJ%22">Tolosa EJ</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Fernandez-Barrena+MG%22">Fernandez-Barrena MG</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Iguchi+E%22">Iguchi E</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22McCleary-Wheeler+AL%22">McCleary-Wheeler AL</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Carr+RM%22">Carr RM</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Almada+LL%22">Almada LL</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Flores+LF%22">Flores LF</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Vera+RE%22">Vera RE</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Alfonse+GW%22">Alfonse GW</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Marks+DL%22">Marks DL</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Hogenson+TL%22">Hogenson TL</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Vrabel+AM%22">Vrabel AM</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Horn+IP%22">Horn IP</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Koenig+AN%22">Koenig AN</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Safgren+SL%22">Safgren SL</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Sigafoos+AN%22">Sigafoos AN</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Erkan+M%22">Erkan M</searchLink>; Department of Surgery, Koc University School of Medicine, Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Romecin-Duran+PA%22">Romecin-Duran PA</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Sarabia+Gonzalez+A%22">Sarabia Gonzalez A</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Zhou+B%22">Zhou B</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Javelaud+D%22">Javelaud D</searchLink>; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France.<br /><searchLink fieldCode="AU" term="%22Marsaud+V%22">Marsaud V</searchLink>; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France.<br /><searchLink fieldCode="AU" term="%22Graham+RP%22">Graham RP</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Mauviel+A%22">Mauviel A</searchLink>; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France.<br /><searchLink fieldCode="AU" term="%22Elsawa+SF%22">Elsawa SF</searchLink>; Department of Molecular, Cellular and Biomedical Sciences, College of Life Sciences and Agriculture, University of New Hampshire, Durham, NH, U.S.A.<br /><searchLink fieldCode="AU" term="%22Fernandez-Zapico+ME%22">Fernandez-Zapico ME</searchLink>; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222984726R%22">The Biochemical journal</searchLink> [Biochem J] 2020 Sep 18; Vol. 477 (17), pp. 3131-3145.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Portland+Press+on+behalf+of+the+Biochemical+Society%22">Published by Portland Press on behalf of the Biochemical Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2984726R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1470-8728 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202646021%22">02646021 </searchLink><i>NLM ISO Abbreviation: </i>Biochem J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32766732
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1042/BCJ20200335
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3131
    Titles:
      – TitleFull: GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tolosa EJ
      – PersonEntity:
          Name:
            NameFull: Fernandez-Barrena MG
      – PersonEntity:
          Name:
            NameFull: Iguchi E
      – PersonEntity:
          Name:
            NameFull: McCleary-Wheeler AL
      – PersonEntity:
          Name:
            NameFull: Carr RM
      – PersonEntity:
          Name:
            NameFull: Almada LL
      – PersonEntity:
          Name:
            NameFull: Flores LF
      – PersonEntity:
          Name:
            NameFull: Vera RE
      – PersonEntity:
          Name:
            NameFull: Alfonse GW
      – PersonEntity:
          Name:
            NameFull: Marks DL
      – PersonEntity:
          Name:
            NameFull: Hogenson TL
      – PersonEntity:
          Name:
            NameFull: Vrabel AM
      – PersonEntity:
          Name:
            NameFull: Horn IP
      – PersonEntity:
          Name:
            NameFull: Koenig AN
      – PersonEntity:
          Name:
            NameFull: Safgren SL
      – PersonEntity:
          Name:
            NameFull: Sigafoos AN
      – PersonEntity:
          Name:
            NameFull: Erkan M
      – PersonEntity:
          Name:
            NameFull: Romecin-Duran PA
      – PersonEntity:
          Name:
            NameFull: Sarabia Gonzalez A
      – PersonEntity:
          Name:
            NameFull: Zhou B
      – PersonEntity:
          Name:
            NameFull: Javelaud D
      – PersonEntity:
          Name:
            NameFull: Marsaud V
      – PersonEntity:
          Name:
            NameFull: Graham RP
      – PersonEntity:
          Name:
            NameFull: Mauviel A
      – PersonEntity:
          Name:
            NameFull: Elsawa SF
      – PersonEntity:
          Name:
            NameFull: Fernandez-Zapico ME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 09
              Text: 2020 Sep 18
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1470-8728
          Numbering:
            – Type: volume
              Value: 477
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: The Biochemical journal
              Type: main
ResultId 1